Authors: BOBERG M AHR HJ BECKERMANN B BUHNER K SIEFERT HM STEINKE W WUNSCHE C HIRAYAMA M

Citation: M. Boberg et al., PHARMACOKINETICS AND METABOLISM OF THE NEW THROMBOXANE A(2) RECEPTOR ANTAGONIST RAMATROBAN IN ANIMALS - 1ST COMMUNICATION - ABSORPTION, CONCENTRATIONS IN PLASMA, METABOLISM, AND EXCRETION AFTER SINGLE ADMINISTRATION TO RATS AND DOGS, Arzneimittel-Forschung, 47(8), 1997, pp. 928-938

Authors: MULLERPEDDINGHAUS R FRUCHTMANN R AHR HJ BECKERMANN B BUHNER K FUGMANN B JUNGE B MATZKE M KOHLSDORFER C RADDATZ S THEISENPOPP P MOHRS KH

Citation: R. Mullerpeddinghaus et al., BAY-X1005, A NEW SELECTIVE INHIBITOR OF LEUKOTRIENE SYNTHESIS - PHARMACOLOGY AND PHARMACOKINETICS, Journal of lipid mediators, 6(1-3), 1993, pp. 245-248

Authors: MULLERPEDDINGHAUS R KOHLSDORFER C THEISENPOPP P FRUCHTMANN R PERZBORN E BECKERMANN B BUHNER K AHR HJ MOHRS KH

Citation: R. Mullerpeddinghaus et al., BAY X1005, A NEW INHIBITOR OF LEUKOTRIENE SYNTHESIS - IN-VIVO INFLAMMATION PHARMACOLOGY AND PHARMACOKINETICS, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 51-57